BMCS Hot Topics: Antibody–Drug Conjugates 

Event
BMCS Hot Topics: Antibody – Drug Conjugates

Dates
Thursday 20th November 2025 (afternoon) 13:00 – 17:00 UK Time

Place
Online event, Zoom

Important links and downloads
X Hashtag – #HotTopicsADCs

Synopsis
The BMCS Hot Topics online meetings are intended to highlight breaking areas of research in fields of science relevant to drug discovery. They will run as stand-alone half-day virtual events, 2-3 times per year. The programme will be targeted towards researchers working who would like to enhance their understanding of these nascent or developing fields.

Antibody-drug conjugates (ADCs), alongside other targeted modalities, effectively enrich target tissues with potent payloads unsuitable for systemic administration. With several recent clinical successes, the number of new ADCs approaching the clinic is rapidly increasing. This meeting aims to highlight the technological advancements and innovations driving these ADCs, while addressing the challenges and opportunities within the field. The Hot Topics session will feature speakers from industry and academia who are at the forefront of ADC design.

Registration
Registration will open shortly. Please contact events@hg3.co.uk if you wish to be notified when registration is open.

Want to become a member?
To join the RSC in order to qualify for discounted registration fees at all RSC, please follow this RSC link.

Sponsorship
The organising committee are seeking sponsorship from organisations supporting the low registration fees offered to students. Registration for sponsorship will be open shortly.

Confirmed Speakers
Mark Petersen, Zymeworks

Elena de Orbe Izquierdo, AstraZeneca

Tom Pillow, Genentech

Organising Committee
Sharan Bagal, AstraZeneca
Daniel O Donovan, AstraZeneca
Helen Aylott, Redx Pharma
Maximillian Lee, AstraZeneca
Charlotte Hardy, Charles River
Karina Chan, GSK
Hannah Fowler, RSC

Secretariat Contact
Hg3 Conferences Ltd
+44 (0)1423 529333
E-mail